Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Capital Leases: 2020-2025

Historic Capital Leases for Maravai Lifesciences Holdings (MRVI) over the last 4 years, with Sep 2025 value amounting to $30.4 million.

  • Maravai Lifesciences Holdings' Capital Leases fell 2.94% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year decrease of 2.94%. This contributed to the annual value of $31.1 million for FY2024, which is 2.48% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Capital Leases stood at $30.4 million, which was down 0.80% from $30.7 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Capital Leases registered a high of $55.9 million during Q1 2021, and its lowest value of $16.6 million during Q1 2023.
  • In the last 3 years, Maravai Lifesciences Holdings' Capital Leases had a median value of $31.3 million in 2024 and averaged $30.0 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Capital Leases spiked by 91.41% in 2024, and later declined by 2.94% in 2025.
  • Maravai Lifesciences Holdings' Capital Leases (Quarterly) stood at $55.3 million in 2021, then reached $31.9 million in 2023, then dropped by 2.48% to $31.1 million in 2024, then dropped by 2.94% to $30.4 million in 2025.
  • Its last three reported values are $30.4 million in Q3 2025, $30.7 million for Q2 2025, and $30.9 million during Q1 2025.